CICLOSPORIN GENFARMA 100 Milligram Capsules, Soft
Страна: Ирландия
Език: английски
Източник: HPRA (Health Products Regulatory Authority)
Данни за продукта
(SPC)
03-06-2024
Понастоящем някои документи за този продукт не са налични, можете да изпратите заявка до нашата служба за клиенти и ние ще ви уведомим веднага щом успеем да ги получим.
Изпрати заяв.
Изпрати заяв.
Активна съставка:
CICLOSPORIN
Предлага се от:
Actavis Group PTC ehf
INN (Международно Name):
CICLOSPORIN
дозиране:
100 Milligram
Лекарствена форма:
Capsules, Soft
Вид предписание :
Product subject to prescription which may be renewed (B)
Статус Оторизация:
Withdrawn
Дата Оторизация:
0000-00-00
Данни за продукта
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Ciclosporin Genfarma 100 mg Soft Capsules
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each capsule contains 100
mg ciclosporin.
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Capsule, soft
Ciclosporin Genfarma 100 mg Capsules are grey soft gelatin capsules with imprinting “DX 100 mg”.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
_ORGAN TRANSPLANTATION_
Prevention of graft rejection following kidney, liver, heart, combined heart-lung, lung or pancreas transplants.
Treatment of transplant rejection in patients previously receiving other immunosuppressive agents.
_BONE MARROW TRANSPLANTATION_
Prevention of graft rejection following bone marrow transplantation and prophylaxis of graft-versus-host disease
(GVHD).
Treatment of established graft-versus-host disease (GVHD).
_PSORIASIS_
Ciclosporin Genfarma are indicated in patients with severe psoriasis in whom conventional therapy is ineffective or
inappropriate.
_ATOPIC DERMATITIS_
Ciclosporin Genfarma are indicated for short term treatment (8 weeks) of patients with severe atopic dermatitis in
whom conventional therapy is ineffective or inappropriate.
_NEPHROTIC SYNDROME_
Ciclosporin Genfarma are indicated in the treatment of adults and children with steroid-dependent and steroid-resistant
nephrotic syndrome owing to glomerular diseases such as minimal change nephropathy, focal segmental
glomerulosclerosis or membranous glomerulonephritis.
Ciclosporin Genfarma can be used to induce remissions and for maintenance treatment.
_RHEUMATOID ARTHRITIS_
Ciclosporin Genfarma are indicated for the treatment of severe, active rheumatoid arthritis in patients in whom classical
slow-acting anti-rheumatic agents are inappropriate or ineffective.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Прочетете целия документ
